VIDEO: Cyclosporine raises new hope for treatment of vernal keratoconjunctivitis
MILAN — In this video perspective at the ESCRS meeting, Dominique Brémond-Gignac, MD, PhD, speaks about cyclosporine as a novel promising treatment for vernal keratoconjunctivitis.
Management of vernal keratoconjunctivitis was the topic of a satellite symposium sponsored by Santen during the World Society of Paediatric Ophthalmology and Strabismus subspecialty day. Cyclosporine has demonstrated safety, efficacy and the ability to reduce the need for corticosteroids in a worldwide study, and it represents a realistic hope for children who have their life heavily affected by this disease.
Collapse
Brémond-Gignac D. Santen satellite symposium: Evolution of VKC management: A multi-perspective approach. Presented at: European Society of Cataract and Refractive Surgeons meeting; Sept. 16-20, 2022; Milan.
Read more about